Amantadine News and Research

RSS
Adamas begins ADS-5102 Phase 2/3 clinical trial in Parkinson's disease

Adamas begins ADS-5102 Phase 2/3 clinical trial in Parkinson's disease

Combination therapies inhibiting P7 could prevent spread of HCV

Combination therapies inhibiting P7 could prevent spread of HCV

Researchers analyze drugs' efficiency on influenza A virus

Researchers analyze drugs' efficiency on influenza A virus

New development in flu prevention & treatment

New development in flu prevention & treatment

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

Adamas Pharmaceuticals presents study results of TCAD therapy in immunocompromised influenza A patients

TCAD therapy superior to double combinations and monotherapy against influenza viruses

TCAD therapy superior to double combinations and monotherapy against influenza viruses

TCAD therapy active and synergistic against drug resistant influenza virus strains

TCAD therapy active and synergistic against drug resistant influenza virus strains

Amantadine binds to and blocks critical M2 proton channel necessary for influenza virus to infect healthy cells

Amantadine binds to and blocks critical M2 proton channel necessary for influenza virus to infect healthy cells

EGCg in green tea inhibits flu infection

EGCg in green tea inhibits flu infection

Grant of $1 million awarded to develop new treatments for dyskinesia

Grant of $1 million awarded to develop new treatments for dyskinesia

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

Adamas Pharmaceuticals expands its Phase 2 TCAD therapy study for influenza A

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

TCAD therapy shows potency against seasonal and novel H1N1 influenza viruses

TCAD therapy shows potency against seasonal and novel H1N1 influenza viruses

Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes

Seeplex FluA ACE subtyping test enables simultaneous detection of four major influenza A subtypes

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

George Rehm and David Mahoney joins Adamas' Board of Directors

George Rehm and David Mahoney joins Adamas' Board of Directors

Merck Serono starts second phase III trial of Safinamide in advanced Parkinson's

Merck Serono starts second phase III trial of Safinamide in advanced Parkinson's

Sinobiopharma secures rights to seven key patents

Sinobiopharma secures rights to seven key patents

Swine influenza confirmed in the U.S.

Swine influenza confirmed in the U.S.

Bird flu becoming more resistant to antivirals

Bird flu becoming more resistant to antivirals